13F HOLDINGS REPORT
Sarissa Capital Management LP
Quarter ended Q1 2024 · Filed May 15, 2024 · Accession 0000899140-24-000608
Total Value
$571.6M
Positions
10
Other Managers
0
Confidential Omitted
No
Holdings (10)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | IRONWOOD PHARMACEUTICALS INC | IRWD | 16,390,000 | $142.8M | 24.97% |
| 2 | BIOGEN INC | BIIB | 643,000 | $138.7M | 24.26% |
| 3 | INNOVIVA INC | INVA | 7,277,000 | $110.9M | 19.40% |
| 4 | GILEAD SCIENCES INC | GILD | 1,103,282 | $80.8M | 14.14% |
| 5 | NEUROCRINE BIOSCIENCES INC | NBIX | 346,426 | $47.8M | 8.36% |
| 6 | AMARIN CORP PLC | AMRN | 24,850,623 | $22.1M | 3.87% |
| 7 | CYTOKINETICS INC | CYTK | 300,000 | $21.0M | 3.68% |
| 8 | BIOCRYST PHARMACEUTICALS INC | BCRX | 1,094,168 | $5.6M | 0.97% |
| 9 | VOR BIOPHARMA INC | VOR | 618,000 | $1.5M | 0.26% |
| 10 | REGULUS THERAPEUTICS INC | 75915K309 | 185,183 | $533,327 | 0.09% |